Navigation Links
Prominent Health Care Executive Joins Stemedica Board Of Directors
Date:12/1/2009

Anthony M. Marlon, MD was elected to the Stemedica Cell Technologies, Inc. (“Stemedica”) Board of Directors at the Company’s November 20th Board Meeting.

(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD was elected to the Stemedica Cell Technologies, Inc. (“Stemedica”) Board of Directors at the Company’s November 20th Board Meeting. Roger J. Howe, PhD, Executive Chairman for Stemedica made the announcement, “We are fortunate to have someone of Dr. Marlon’s experience, expertise and stature joining our Board. He brings first hand experience to our Board as a physician and as a prominent business leader within the health care industry for the past thirty seven years.”

Dr. Marlon was Chairman of the Board and Chief Executive Officer of Sierra Health Services, Inc. (“Sierra”), a publicly traded healthcare company headquartered in Las Vegas, Nevada. Founded in 1984, Sierra was a diversified managed healthcare company that provided and/or administered benefit plans for employers, government programs and individuals predominately in Nevada. Sierra was comprised of a family of health-related subsidiaries including Health Plan of Nevada, Nevada’s largest health maintenance organization (HMO). In February of 2008, Sierra and its subsidiaries became part of United Healthcare where he was asked to serve as a consultant through February of this year.

Dr. Marlon was a member of the Board of Directors of America’s Health Insurance Plans (AHIP), and remains a Board Member of the Nevada Development Authority and the University of Nevada Las Vegas (UNLV) Foundation. In 1992, Dr. Marlon was appointed to the Federal Task Force on Long Term Health Care Policies. For thirteen years, Dr. Marlon’s leadership skills were called on as a member of the Government Affairs Committee of the Las Vegas Chamber of Commerce. “Dr. Marlon provides Stemedica with an expertise in health care development, regulatory approval processes and insurance reimbursement models that is unparalleled,” said Maynard A. Howe, PhD, Stemedica’s Vice Chairman & CEO. “Anthony will be invaluable to both our Board and our Senior Management as we help to pioneer regulatory and reimbursement models for countries around the world.”

Dr. Marlon was born in New York City. He attended the College of the Holy Cross in Worcester, Massachusetts where he received a Bachelor of Science degree in 1963. He earned his Doctor of Medicine degree at State University of New York in 1967. At Stanford University Hospital in Palo Alto, California, he served as a medical intern from 1967-1968; as an internal medicine resident from 1968-1970; and as a Cardiology Fellow from 1970-1972. Dr. Marlon moved to Las Vegas in July of 1972 and was affiliated with University Medical Center as Chief of the Division of Cardiology. Dr. Marlon has been a speaker for various medical institutions, universities, and health groups and has written numerous cardiology related articles for medical publications.

About Stemedica Cell Technologies
Stemedica Cell Technologies Inc. (www.stemedica.com) develops and manufactures allogeneic adult stem cells sold worldwide for research and clinical purposes. Stemedica is headquartered in San Diego, California.

For more information regarding this Media Release or Stemedica Cell Technologies, contact Dave McGuigan at dmcguigan (at) stemedica.com.

###

Read the full story at http://www.prweb.com/releases/stemedica-board/anthony-marlon/prweb3281184.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice
2. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
3. Prominent Chick Lit Novelist Laura Zigman Joins HealthCentrals MyBreastCancerNetwork.com as Expert
4. Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors
5. Prominent Respiratory Therapist and Author Joins StopSmokingConnection.com as a COPD Expert
6. Prominent Health Care Executive, Kevin Kraushaar, Joins Triadvocates LLC as Managing Principal of DC Office
7. Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com
8. Highmark, Prominent Part of Pittsburgh City Skyline, to Go Dark for One Hour to Support the Environment
9. Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant
10. Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute
11. ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prominent Health Care Executive Joins Stemedica Board Of Directors
(Date:9/25/2017)... ... September 25, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that two of its ... of bioassays at two upcoming conferences. , At the BEBPA 10th Annual Bioassay ...
(Date:9/25/2017)... ... ... NCPDP Foundation , a 501(c)(3) nonprofit charitable organization ... grant to Johns Hopkins Medicine to address patient safety risk by implementing CancelRx ... a prescription already submitted to a pharmacy. Studies indicate that up to 3% ...
(Date:9/25/2017)... ... September 25, 2017 , ... Lean ... efficiency. The principle of First-Defect-Stop for laboratory weighing is designed to ... the chance to have negative consequences on downstream processes. , If a problem ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... technology-enabled services supporting clinical research, today announces that 30 of its domain ... the drug development lifecycle at upcoming industry conferences and webinars. Drawing on ...
(Date:9/25/2017)... ... September 25, 2017 , ... Ron Norman, CEO of Team ... upper-level executives speaking at a business luncheon today, "It is tantamount to forgetting ... asset to be fully realized and activated by the corporations that recognize their ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Healthcare Conference at the Grand Hyatt hotel in New ... 2017 at 11:40 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
Breaking Medicine Technology: